News
Topline data from both Phase 3 trials is expected in the second quarter of 2026, with NDA submission to follow thereafter.
Cataracts and glaucoma, common in older adults, impact vision differently. Knowing their causes, signs, and treatments helps ...
More than 4.2 million Americans live with glaucoma, a leading cause of vision loss in the nation. Although there is no cure ...
Most studies on the combination eye drop brinzolamide and brimonidine (Symbrinza) used the drug three times daily.
Serious side effects from H2 blockers are rare. Like PPIs, they can sometimes cause low B12 levels. Headaches and agitation ...
I am a 74-year-old woman who was diagnosed with open angle glaucoma several years ago. My ophthalmologist has directed me to ...
DEAR DR. ROACH: I am a 74-year-old woman diagnosed with open angle glaucoma several years ago. My ophthalmologist directed me to use ...
Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.
The patient information guide from Simbrinza says to use it no more than twice a day. I talked to my doctor about this last time I saw him and didn't get a satisfactory response. My eye pressure was ...
I am a 74-year-old woman who was diagnosed with open angle glaucoma several years ago. My ophthalmologist has directed me to ...
A new study on glaucoma, a leading cause of irreversible blindness, offers a fresh understanding of how the disease ...
The study by OHSU researchers unlocks potential new treatment options for a leading cause of blindness In a new study, OHSU ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results